Literature DB >> 22679563

SUMO-activating SAE1 transcription is positively regulated by Myc.

Stefano Amente1, Miriam Lubrano Lavadera, Giacomo Di Palo, Barbara Majello.   

Abstract

Myc protein plays a fundamental role in regulation of cell cycle, proliferation, differentiation and apoptosis by modulating the expression of a large number of targets. Here we report the transactivation ability of the human Myc protein to activate the SUMO-activating enzyme SAE1 transcription. We found that Myc activates SAE1 transcription via direct binding to canonical E-Boxes sequences located close to the SAE1 transcription start site. A recent report has highlighted the crucial role of the SAE gene expression in Myc mediated oncogenesis. Our study adds new insight in this context since we show here that Myc directly activates SAE1 transcription, suggesting that Myc oncogenic activity which depends on SAE1 is ensured by Myc itself through direct binding and transcriptional activation of SAE1 expression.

Entities:  

Keywords:  Myc; SAE1; SUMOylation; transcription

Year:  2012        PMID: 22679563      PMCID: PMC3365806     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  13 in total

1.  Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

Review 2.  SUMO: a history of modification.

Authors:  Ronald T Hay
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

3.  Myc-binding-site recognition in the human genome is determined by chromatin context.

Authors:  Ernesto Guccione; Francesca Martinato; Giacomo Finocchiaro; Lucilla Luzi; Laura Tizzoni; Valentina Dall' Olio; Giuseppe Zardo; Clara Nervi; Loris Bernard; Bruno Amati
Journal:  Nat Cell Biol       Date:  2006-06-11       Impact factor: 28.824

Review 4.  Reflecting on 25 years with MYC.

Authors:  Natalie Meyer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

5.  Cell type specificity of chromatin organization mediated by CTCF and cohesin.

Authors:  Chunhui Hou; Ryan Dale; Ann Dean
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

6.  Myc: the beauty and the beast.

Authors:  Amanda R Wasylishen; Linda Z Penn
Journal:  Genes Cancer       Date:  2010-06

7.  A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.

Authors:  Jessica D Kessler; Kristopher T Kahle; Tingting Sun; Kristen L Meerbrey; Michael R Schlabach; Earlene M Schmitt; Samuel O Skinner; Qikai Xu; Mamie Z Li; Zachary C Hartman; Mitchell Rao; Peng Yu; Rocio Dominguez-Vidana; Anthony C Liang; Nicole L Solimini; Ronald J Bernardi; Bing Yu; Tiffany Hsu; Ido Golding; Ji Luo; C Kent Osborne; Chad J Creighton; Susan G Hilsenbeck; Rachel Schiff; Chad A Shaw; Stephen J Elledge; Thomas F Westbrook
Journal:  Science       Date:  2011-12-08       Impact factor: 47.728

8.  Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor.

Authors:  Daniela Alfano; Giuseppina Votta; Almut Schulze; Julian Downward; Mario Caputi; Maria Patrizia Stoppelli; Ingram Iaccarino
Journal:  Mol Cell Biol       Date:  2010-02-01       Impact factor: 4.272

9.  Myc and PI3K/AKT signaling cooperatively repress FOXO3a-dependent PUMA and GADD45a gene expression.

Authors:  Stefano Amente; Jiyuan Zhang; Miriam Lubrano Lavadera; Luigi Lania; Enrico Vittorio Avvedimento; Barbara Majello
Journal:  Nucleic Acids Res       Date:  2011-08-10       Impact factor: 16.971

10.  Analysis of Myc-induced histone modifications on target chromatin.

Authors:  Francesca Martinato; Matteo Cesaroni; Bruno Amati; Ernesto Guccione
Journal:  PLoS One       Date:  2008-11-05       Impact factor: 3.240

View more
  16 in total

1.  High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.

Authors:  Duan-Fang Shao; Xiao-Hong Wang; Zi-Yu Li; Xiao-Fang Xing; Xiao-Jing Cheng; Ting Guo; Hong Du; Ying Hu; Bin Dong; Ning Ding; Lin Li; Shen Li; Qing-Da Li; Xian-Zi Wen; Lian-Hai Zhang; Jia-Fu Ji
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

2.  Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

Authors:  Alexander Hoellein; Mohammad Fallahi; Stephanie Schoeffmann; Sabine Steidle; Franz X Schaub; Martina Rudelius; Iina Laitinen; Lisa Nilsson; Andrei Goga; Christian Peschel; Jonas A Nilsson; John L Cleveland; Ulrich Keller
Journal:  Blood       Date:  2014-08-20       Impact factor: 22.113

3.  High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.

Authors:  Duan-Fang Shao; Xiao-Hong Wang; Zi-Yu Li; Xiao-Fang Xing; Xiao-Jing Cheng; Ting Guo; Hong Du; Ying Hu; Bin Dong; Ning Ding; Lin Li; Shen Li; Qing-Da Li; Xian-Zi Wen; Lian-Hai Zhang; Jia-Fu Ji
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 4.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

5.  Bioinformatics-based analysis of SUMOylation-related genes in hepatocellular carcinoma reveals a role of upregulated SAE1 in promoting cell proliferation.

Authors:  Yang Liu; Xiang Wang; Xingzhi Zeng; Yinghua Wu; Xinrong Liu; Juan Tan; Xiaoyan Li
Journal:  Open Med (Wars)       Date:  2022-07-06

6.  The acute transcriptomic and proteomic response of HC-04 hepatoma cells to hepatocyte growth factor and its implications for Plasmodium falciparum sporozoite invasion.

Authors:  Dingyin Tao; Jonas G King; Rebecca E Tweedell; Philipp J Jost; Justin A Boddey; Rhoel R Dinglasan
Journal:  Mol Cell Proteomics       Date:  2014-02-16       Impact factor: 5.911

Review 7.  Starting and stopping SUMOylation. What regulates the regulator?

Authors:  Felicity Z Watts
Journal:  Chromosoma       Date:  2013-06-28       Impact factor: 4.316

8.  An immunohistochemical panel of three small ubiquitin-like modifier genes predicts outcomes of patients with triple-negative breast cancer.

Authors:  Yuxiang Lin; Qingshui Wang; Yingying Lin; Meichen Jiang; Han Xiao; Jie Zhang; Rongrong Guo; Shaohong Kang; Yao Lin; Chuangui Song
Journal:  Gland Surg       Date:  2021-03

9.  The deubiquitinase USP36 promotes snoRNP group SUMOylation and is essential for ribosome biogenesis.

Authors:  Hyunju Ryu; Xiao-Xin Sun; Yingxiao Chen; Yanping Li; Xiaoyan Wang; Roselyn S Dai; Hong-Ming Zhu; John Klimek; Larry David; Lev M Fedorov; Yoshiaki Azuma; Rosalie C Sears; Mu-Shui Dai
Journal:  EMBO Rep       Date:  2021-04-14       Impact factor: 9.071

10.  SUMOylation of Myc-family proteins.

Authors:  Arianna Sabò; Mirko Doni; Bruno Amati
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.